Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial

Aim: In patients with hyperlipidemia, intolerance to statins presents a challenge in reducing the risk of events associated with cardiovascular disease. This phase 3, randomized, double-blind trial in Japanese patients with statin intolerance aimed to evaluate the efficacy and safety of evolocumab v...

Descripción completa

Detalles Bibliográficos
Autores principales: Koba, Shinji, Inoue, Ikuo, Cyrille, Marcoli, Lu, Chen, Inomata, Hyoe, Shimauchi, Junichiro, Kajinami, Kouji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japan Atherosclerosis Society 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242224/
https://www.ncbi.nlm.nih.gov/pubmed/31748467
http://dx.doi.org/10.5551/jat.50963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242224/
https://www.ncbi.nlm.nih.gov/pubmed/31748467
http://dx.doi.org/10.5551/jat.50963

Ejemplares similares